Literature DB >> 20459552

Aristolochic acid nephropathy revisited: a place for innate and adaptive immunity?

Agnieszka A Pozdzik1, Alix Berton, Heinz H Schmeiser, Wassim Missoum, Christine Decaestecker, Isabelle J Salmon, Jean-Louis Vanherweghem, Joëlle L Nortier.   

Abstract

AIMS: The histological features of aristolochic acid nephropathy (AAN) consist of paucicellular interstitial fibrosis, severe tubular atrophy, and almost intact glomeruli with media lesions of interlobular arteries. As an early phase of interstitial inflammation preceded peritubular fibrosis in the rat model of AAN, the aim was to investigate the presence of inflammatory cells in human AAN. METHODS AND
RESULTS: Reports of confirmed cases and case series of AAN were reviewed in terms of interstitial inflammation and found to have very conflicting results. This prompted us to search for and characterize inflammatory cells within the native kidneys provided from four end-stage AAN patients. Prior aristolochic acid exposure was attested by the intrarenal presence of the typical aristolactam I-derived DNA adduct. Besides the tubulointerstitial lesions usually seen in the cortex, a massive infiltration of macrophages, T and B lymphocytes was detected by immunohistochemistry in the medullary rays and in the outer medullae with some extension to the upper cortical labyrinth.
CONCLUSIONS: In parallel with histological findings reported in the rat model, inflammatory cells are present preferentially in the interstitium of the medullary rays and of the outer medulllae in renal interstitium from human AAN cases, even in the terminal stages. Further studies must be undertaken to determine the respective roles of innate and adaptive immunity in the progression of AAN.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20459552     DOI: 10.1111/j.1365-2559.2010.03509.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  13 in total

1.  Macrophage-derived, LRG1-enriched extracellular vesicles exacerbate aristolochic acid nephropathy in a TGFβR1-dependent manner.

Authors:  Wenjuan Jiang; Chuanting Xu; Songbing Xu; Wan Su; Changlin Du; Jiahui Dong; Rui Feng; Cheng Huang; Jun Li; Taotao Ma
Journal:  Cell Biol Toxicol       Date:  2021-10-22       Impact factor: 6.819

Review 2.  Experimental Aristolochic Acid Nephropathy: A Relevant Model to Study AKI-to-CKD Transition.

Authors:  Thomas Baudoux; Inès Jadot; Anne-Emilie Declèves; Marie-Hélène Antoine; Jean-Marie Colet; Olivia Botton; Eric De Prez; Agnieszka Pozdzik; Cécile Husson; Nathalie Caron; Joëlle L Nortier
Journal:  Front Med (Lausanne)       Date:  2022-05-04

3.  Clinical Analysis of a Hypokalemic Salt-losing Tubulopathy Case.

Authors:  Wei Zheng; Quan Hong; Xue-Guang Zhang; Xiao-Dong Geng; Guang-Yan Cai; Xiang-Mei Chen; Di Wu
Journal:  Chin Med J (Engl)       Date:  2016-03-05       Impact factor: 2.628

4.  Targeting c-fms kinase attenuates chronic aristolochic acid nephropathy in mice.

Authors:  Xiao Y Dai; Xiao R Huang; Li Zhou; Lin Zhang; Ping Fu; Carl Manthey; David J Nikolic-Paterson; Hui Y Lan
Journal:  Oncotarget       Date:  2016-03-08

5.  Circulating (CD3(-)CD19(+)CD20(-)IgD(-)CD27(high)CD38(high)) Plasmablasts: A Promising Cellular Biomarker for Immune Activity for Anti-PLA2R1 Related Membranous Nephropathy?

Authors:  Agnieszka Pozdzik; Ingrid Beukinga; Chunyan Gu-Trantien; Karen Willard-Gallo; Joëlle Nortier; Olivier Pradier
Journal:  Mediators Inflamm       Date:  2016-07-14       Impact factor: 4.711

6.  Restored nitric oxide bioavailability reduces the severity of acute-to-chronic transition in a mouse model of aristolochic acid nephropathy.

Authors:  Inès Jadot; Vanessa Colombaro; Blanche Martin; Isabelle Habsch; Olivia Botton; Joëlle Nortier; Anne-Emilie Declèves; Nathalie Caron
Journal:  PLoS One       Date:  2017-08-23       Impact factor: 3.240

Review 7.  An Integrated View of Aristolochic Acid Nephropathy: Update of the Literature.

Authors:  Inès Jadot; Anne-Emilie Declèves; Joëlle Nortier; Nathalie Caron
Journal:  Int J Mol Sci       Date:  2017-01-29       Impact factor: 5.923

8.  CD4+ and CD8+ T Cells Exert Regulatory Properties During Experimental Acute Aristolochic Acid Nephropathy.

Authors:  Thomas Baudoux; Cécile Husson; Eric De Prez; Inès Jadot; Marie-Hélène Antoine; Joëlle L Nortier; Jean-Michel Hougardy
Journal:  Sci Rep       Date:  2018-03-28       Impact factor: 4.379

9.  Acute and Subchronic Toxicity Studies of Aristolochic Acid A in Tianfu Broilers.

Authors:  Dan Xu; Chonglin Ran; Lizi Yin; Juchun Lin; Hualin Fu; Xi Peng; Xiaoling Zhao; Gang Shu
Journal:  Animals (Basel)       Date:  2021-05-27       Impact factor: 2.752

10.  Blocking TGF-β Signaling Pathway Preserves Mitochondrial Proteostasis and Reduces Early Activation of PDGFRβ+ Pericytes in Aristolochic Acid Induced Acute Kidney Injury in Wistar Male Rats.

Authors:  Agnieszka A Pozdzik; Laetitia Giordano; Gang Li; Marie-Hélène Antoine; Nathalie Quellard; Julie Godet; Eric De Prez; Cécile Husson; Anne-Emilie Declèves; Volker M Arlt; Jean-Michel Goujon; Isabelle Brochériou-Spelle; Steven R Ledbetter; Nathalie Caron; Joëlle L Nortier
Journal:  PLoS One       Date:  2016-07-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.